Flynn James E
28 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | NUVL | Nuvalent, Inc. | D | 8,299,225 | $124.00 | $1.0B | filing |
| 2026-07-15 | NUVL | Nuvalent, Inc. | D | 8,299,225 | $124.00 | $1.0B | filing |
| 2026-07-15 | NUVL | Nuvalent, Inc. | D | 650,000 | $124.00 | $80.6M | filing |
| 2026-07-15 | NUVL | Nuvalent, Inc. | U | 5,146 | $124.00 | $638,104.00 | filing |
| 2026-07-15 | NUVL | Nuvalent, Inc. | U | 5,146 | $124.00 | $638,104.00 | filing |
| 2026-07-15 | NUVL | Nuvalent, Inc. | D | 3,444 | $124.00 | $427,056.00 | filing |
| 2026-06-16 | NUVL | Nuvalent, Inc. | Award | 3,444 | $0.00 | $0.00 | filing |
| 2026-06-11 | PBLS | Parabilis Medicines, Inc. | C | 407,132 | — | — | filing |
| 2026-06-11 | PBLS | Parabilis Medicines, Inc. | C | 407,132 | — | — | filing |
| 2026-06-11 | PBLS | Parabilis Medicines, Inc. | C | 122,990 | — | — | filing |
| 2026-06-11 | PBLS | Parabilis Medicines, Inc. | C | 122,990 | — | — | filing |
| 2026-06-11 | PBLS | Parabilis Medicines, Inc. | C | 149,238 | — | — | filing |
| 2026-06-11 | PBLS | Parabilis Medicines, Inc. | C | 149,238 | — | — | filing |
| 2026-06-11 | PBLS | Parabilis Medicines, Inc. | C | 260,992 | — | — | filing |
| 2026-06-11 | PBLS | Parabilis Medicines, Inc. | C | 260,992 | — | — | filing |
| 2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Buy | 2,000,000 | $5.00 | $10.0M | filing |
| 2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Buy | 1,084,012 | $5.00 | $5.4M | filing |
| 2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Buy | 1,084,010 | $5.00 | $5.4M | filing |
| 2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Buy | 831,978 | $5.00 | $4.2M | filing |
| 2025-11-24 | NUVL | Nuvalent, Inc. | Sale | 371,287 | $95.45 | $35.4M | filing |
| 2025-11-24 | NUVL | Nuvalent, Inc. | Sale | 371,287 | $95.45 | $35.4M | filing |
| 2025-07-31 | LRMR | Larimar Therapeutics, Inc. | Buy | 3,387,539 | $3.20 | $10.8M | filing |
| 2025-07-31 | LRMR | Larimar Therapeutics, Inc. | Buy | 3,387,529 | $3.20 | $10.8M | filing |
| 2025-07-31 | LRMR | Larimar Therapeutics, Inc. | Buy | 2,599,932 | $3.20 | $8.3M | filing |
| 2025-06-27 | SPRY | ARS Pharmaceuticals, Inc. | Sale | 370,075 | $18.46 | $6.8M | filing |
| 2025-06-27 | SPRY | ARS Pharmaceuticals, Inc. | Sale | 370,074 | $18.46 | $6.8M | filing |
| 2025-06-18 | NUVL | Nuvalent, Inc. | Award | 2,647 | $0.00 | $0.00 | filing |
| 2025-06-18 | NUVL | Nuvalent, Inc. | Award | 2,647 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.